The hemophagocytic syndrome/macrophage activation syndrome: a final common pathway of a cytokine storm.
Szyper-Kravitz
Martine
M
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D002648:Child; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D000068800:Etanercept; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D051359:Lymphohistiocytosis, Hemophagocytic / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D055501:Macrophage Activation Syndrome / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D018124:Receptors, Tumor Necrosis Factor; D055815:Young Adult
D018501:Antirheumatic Agents; D005938:Glucocorticoids; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept